Severe Pediatric Asthma Therapy: Mepolizumab

There is a growing need for advanced treatment in children with persistent and severe asthma symptoms. As a matter of fact, between 2 and 5% of asthmatic children experience repeated hospitalizations and poor quality of life despite optimized treatment with inhaled glucocorticoid plus a second contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Ullmann, Nicola, Peri, Francesca, Florio, Olivia, Porcaro, Federica, Profeti, Elisa, Onofri, Alessandro, Cutrera, Renato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283570/
https://www.ncbi.nlm.nih.gov/pubmed/35844748
http://dx.doi.org/10.3389/fped.2022.920066

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283570/
https://www.ncbi.nlm.nih.gov/pubmed/35844748
http://dx.doi.org/10.3389/fped.2022.920066

Ejemplares similares